Drugmaker Pfizer has signed a deal with a United Nations-backed group to let other manufacturers make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world's population.

Join The Ecosystem

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}